These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30909832)

  • 41. Pharmacokinetics of Enarodustat in Non-Japanese and Japanese Healthy Subjects and in Patients With End-Stage Renal Disease on Hemodialysis.
    Pai SM; Kambhampati SRP; Naruhashi S; Yamada H
    Clin Pharmacol Drug Dev; 2023 Jul; 12(7):683-690. PubMed ID: 37203396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic study of an oral cephalosporin, cefdinir, in hemodialysis patients.
    Hishida A; Ohishi K; Nagashima S; Kanamaru M; Obara M; Kitada A
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1718-21. PubMed ID: 9661010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients.
    Grossman EB; Swan SK; Muirhead GJ; Gaffney M; Chung M; DeRiesthal H; Chow D; Raij L
    Kidney Int; 2004 Jul; 66(1):367-74. PubMed ID: 15200445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series.
    Lunardi G; Armirotti A; Nicodemo M; Cavallini L; Damonte G; Vannozzi MO; Venturini M
    Clin Ther; 2009 Aug; 31(8):1812-9. PubMed ID: 19808140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
    Robson R; Buttimore A; Lynn K; Brewster M; Ward P
    Nephrol Dial Transplant; 2006 Sep; 21(9):2556-62. PubMed ID: 16799169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multi-dose pharmacokinetic study of dalteparin in haemodialysis patients.
    Perry SL; O'Shea SI; Byrne S; Szczech LA; Ortel TL
    Thromb Haemost; 2006 Dec; 96(6):750-5. PubMed ID: 17139369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald DL
    Epilepsy Res; 2014 Jul; 108(5):891-901. PubMed ID: 24725807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
    Nguyen E; Coleman CI; Kohn CG; Weeda ER
    Int J Cardiol; 2018 Dec; 273():34-38. PubMed ID: 30266352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Challenges of providing maintenance hemodialysis in a resource poor country: Experience from a single teaching hospital in Lagos, Southwest Nigeria.
    Bello BT; Raji YR; Sanusi I; Braimoh RW; Amira OC; Mabayoje OM
    Hemodial Int; 2013 Jul; 17(3):427-33. PubMed ID: 23374329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis.
    Bleyer AJ; Wright D; Alcorn H
    Clin Nephrol; 2015 May; 83(5):286-92. PubMed ID: 25816806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis.
    Tejani A; Alexander S; Ettenger R; Lerner G; Zimmerman J; Kohaut E; Briscoe DM
    Pediatr Transplant; 2004 Apr; 8(2):151-60. PubMed ID: 15049795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis.
    Mistry GC; Majumdar AK; Swan S; Sica D; Fisher A; Xu Y; Hesney M; Xi L; Wagner JA; Deutsch PJ
    J Clin Pharmacol; 2006 Oct; 46(10):1128-38. PubMed ID: 16988201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical experience with ranolazine in a veteran population with chronic stable angina.
    Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
    Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats.
    Mashayekhi-Sardoo H; Kamali H; Mehri S; Sahebkar A; Imenshahidi M; Mohammadpour AH
    Iran J Basic Med Sci; 2022 Jul; 25(7):865-870. PubMed ID: 36033953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of treprostinil diolamine in subjects with end-stage renal disease on or off dialysis.
    Jenkins A; Wang-Smith L; Marbury T; Laliberte K
    J Cardiovasc Pharmacol; 2013 Apr; 61(4):272-6. PubMed ID: 23188123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Eyler RF; Heung M; Pleva M; Sowinski KM; Park PK; Napolitano LM; Mueller BA
    Pharmacotherapy; 2012 Dec; 32(12):1061-9. PubMed ID: 23208833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
    Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
    Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.